8KDJ
 
 | |
8KDH
 
 | Structure of LAT1-CD98hc in complex with BCH, focused on TMD | 分子名称: | (1~{S},2~{R},4~{R})-2-azanylbicyclo[2.2.1]heptane-2-carboxylic acid, 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine, 4F2 cell-surface antigen heavy chain, ... | 著者 | Lee, Y. | 登録日 | 2023-08-09 | 公開日 | 2025-02-12 | 最終更新日 | 2025-02-26 | 実験手法 | ELECTRON MICROSCOPY (3.78 Å) | 主引用文献 | Structural basis of anticancer drug recognition and amino acid transport by LAT1. Nat Commun, 16, 2025
|
|
8KDD
 
 | |
8KDP
 
 | |
8KDI
 
 | |
8KDF
 
 | Structure of LAT1-CD98hc in complex with JPH203, focused on TMD | 分子名称: | 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine, 4F2 cell-surface antigen heavy chain, CHOLESTEROL, ... | 著者 | Lee, Y. | 登録日 | 2023-08-09 | 公開日 | 2025-02-12 | 最終更新日 | 2025-02-26 | 実験手法 | ELECTRON MICROSCOPY (3.89 Å) | 主引用文献 | Structural basis of anticancer drug recognition and amino acid transport by LAT1. Nat Commun, 16, 2025
|
|
8KDG
 
 | Structure of LAT1-CD98hc-Fab170 in complex with BCH, consensus map | 分子名称: | (1~{S},2~{R},4~{R})-2-azanylbicyclo[2.2.1]heptane-2-carboxylic acid, 2-acetamido-2-deoxy-beta-D-glucopyranose, 4F2 cell-surface antigen heavy chain, ... | 著者 | Lee, Y. | 登録日 | 2023-08-09 | 公開日 | 2025-02-12 | 最終更新日 | 2025-02-26 | 実験手法 | ELECTRON MICROSCOPY (3.68 Å) | 主引用文献 | Structural basis of anticancer drug recognition and amino acid transport by LAT1. Nat Commun, 16, 2025
|
|
8KDO
 
 | Structure of LAT1-CD98hc in complex with melphalan, focused on TMD | 分子名称: | (2~{S})-2-azanyl-3-[4-[bis(2-chloroethyl)amino]phenyl]propanoic acid, 4F2 cell-surface antigen heavy chain, Large neutral amino acids transporter small subunit 1 | 著者 | Lee, Y. | 登録日 | 2023-08-09 | 公開日 | 2025-02-12 | 最終更新日 | 2025-02-26 | 実験手法 | ELECTRON MICROSCOPY (4.12 Å) | 主引用文献 | Structural basis of anticancer drug recognition and amino acid transport by LAT1. Nat Commun, 16, 2025
|
|
6L2G
 
 | Crystal structure of Aspergillus fumigatus mitochondrial acetyl-CoA acetyltransferase | 分子名称: | Acetyl-CoA-acetyltransferase, putative | 著者 | Zhang, Y, Wei, W, Raimi, O.G, Ferenbach, A.T, Fang, W. | 登録日 | 2019-10-03 | 公開日 | 2020-02-12 | 最終更新日 | 2024-10-23 | 実験手法 | X-RAY DIFFRACTION (2.41 Å) | 主引用文献 | Aspergillus fumigatus Mitochondrial Acetyl Coenzyme A Acetyltransferase as an Antifungal Target. Appl.Environ.Microbiol., 86, 2020
|
|
7VR8
 
 | Inward-facing structure of human EAAT2 in the substrate-free state | 分子名称: | (3beta,14beta,17beta,25R)-3-[4-methoxy-3-(methoxymethyl)butoxy]spirost-5-en, 1,2-DIACYL-SN-GLYCERO-3-PHOSPHOCHOLINE, CHOLESTEROL, ... | 著者 | Kato, T, Kusakizako, T, Yamashita, K, Nishizawa, T, Nureki, O. | 登録日 | 2021-10-22 | 公開日 | 2022-08-10 | 最終更新日 | 2024-06-26 | 実験手法 | ELECTRON MICROSCOPY (3.58 Å) | 主引用文献 | Structural insights into inhibitory mechanism of human excitatory amino acid transporter EAAT2. Nat Commun, 13, 2022
|
|
7VR7
 
 | Inward-facing structure of human EAAT2 in the WAY213613-bound state | 分子名称: | (2S)-2-azanyl-4-[[4-[2-bromanyl-4,5-bis(fluoranyl)phenoxy]phenyl]amino]-4-oxidanylidene-butanoic acid, (3beta,14beta,17beta,25R)-3-[4-methoxy-3-(methoxymethyl)butoxy]spirost-5-en, 1,2-DIACYL-SN-GLYCERO-3-PHOSPHOCHOLINE, ... | 著者 | Kato, T, Kusakizako, T, Yamashita, K, Nishizawa, T, Nureki, O. | 登録日 | 2021-10-22 | 公開日 | 2022-08-10 | 最終更新日 | 2024-06-26 | 実験手法 | ELECTRON MICROSCOPY (3.49 Å) | 主引用文献 | Structural insights into inhibitory mechanism of human excitatory amino acid transporter EAAT2. Nat Commun, 13, 2022
|
|
7N6Z
 
 | Crystal Structure of PI5P4KIIAlpha | 分子名称: | Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha, SULFATE ION | 著者 | Chen, S, Ha, Y. | 登録日 | 2021-06-09 | 公開日 | 2021-06-30 | 最終更新日 | 2023-10-18 | 実験手法 | X-RAY DIFFRACTION (2.2 Å) | 主引用文献 | Pharmacological inhibition of PI5P4K alpha / beta disrupts cell energy metabolism and selectively kills p53-null tumor cells. Proc.Natl.Acad.Sci.USA, 118, 2021
|
|
7N7N
 
 | Crystal Structure of PI5P4KIIAlpha complex with Volasertib | 分子名称: | N-{trans-4-[4-(cyclopropylmethyl)piperazin-1-yl]cyclohexyl}-4-{[(7R)-7-ethyl-5-methyl-8-(1-methylethyl)-6-oxo-5,6,7,8-tetrahydropteridin-2-yl]amino}-3-methoxybenzamide, Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha, SULFATE ION | 著者 | Chen, S, Ha, Y. | 登録日 | 2021-06-10 | 公開日 | 2021-06-30 | 最終更新日 | 2023-10-18 | 実験手法 | X-RAY DIFFRACTION (2.3 Å) | 主引用文献 | Pharmacological inhibition of PI5P4K alpha / beta disrupts cell energy metabolism and selectively kills p53-null tumor cells. Proc.Natl.Acad.Sci.USA, 118, 2021
|
|
7N7O
 
 | Crystal Structure of PI5P4KIIAlpha complex with Palbociclib | 分子名称: | 6-ACETYL-8-CYCLOPENTYL-5-METHYL-2-[(5-PIPERAZIN-1-YLPYRIDIN-2-YL)AMINO]PYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONE, Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha, SULFATE ION | 著者 | Chen, S, Ha, Y. | 登録日 | 2021-06-10 | 公開日 | 2021-06-30 | 最終更新日 | 2023-10-18 | 実験手法 | X-RAY DIFFRACTION (2.7 Å) | 主引用文献 | Pharmacological inhibition of PI5P4K alpha / beta disrupts cell energy metabolism and selectively kills p53-null tumor cells. Proc.Natl.Acad.Sci.USA, 118, 2021
|
|
7N7J
 
 | Crystal Structure of PI5P4KIIAlpha complex with AMPPNP | 分子名称: | MANGANESE (II) ION, PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER, Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha, ... | 著者 | Chen, S, Ha, Y. | 登録日 | 2021-06-10 | 公開日 | 2021-06-30 | 最終更新日 | 2023-10-18 | 実験手法 | X-RAY DIFFRACTION (2.1 Å) | 主引用文献 | Pharmacological inhibition of PI5P4K alpha / beta disrupts cell energy metabolism and selectively kills p53-null tumor cells. Proc.Natl.Acad.Sci.USA, 118, 2021
|
|
7N7M
 
 | Crystal Structure of PI5P4KIIAlpha complex with BI-2536 | 分子名称: | 4-{[(7R)-8-cyclopentyl-7-ethyl-5-methyl-6-oxo-5,6,7,8-tetrahydropteridin-2-yl]amino}-3-methoxy-N-(1-methylpiperidin-4-yl)benzamide, Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha, SULFATE ION | 著者 | Chen, S, Ha, Y. | 登録日 | 2021-06-10 | 公開日 | 2021-06-30 | 最終更新日 | 2023-10-18 | 実験手法 | X-RAY DIFFRACTION (2.6 Å) | 主引用文献 | Pharmacological inhibition of PI5P4K alpha / beta disrupts cell energy metabolism and selectively kills p53-null tumor cells. Proc.Natl.Acad.Sci.USA, 118, 2021
|
|
7N7K
 
 | Crystal Structure of PI5P4KIIAlpha complex with AMPPNP | 分子名称: | MANGANESE (II) ION, PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER, Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha, ... | 著者 | Chen, S, Ha, Y. | 登録日 | 2021-06-10 | 公開日 | 2021-06-30 | 最終更新日 | 2023-10-18 | 実験手法 | X-RAY DIFFRACTION (2 Å) | 主引用文献 | Pharmacological inhibition of PI5P4K alpha / beta disrupts cell energy metabolism and selectively kills p53-null tumor cells. Proc.Natl.Acad.Sci.USA, 118, 2021
|
|
7N81
 
 | Crystal Structure of PI5P4KIIBeta complex with CC260 | 分子名称: | (7R)-8-cyclopentyl-7-(cyclopentylmethyl)-2-[(3,5-dichloro-4-hydroxyphenyl)amino]-5-methyl-7,8-dihydropteridin-6(5H)-one, Phosphatidylinositol 5-phosphate 4-kinase type-2 beta | 著者 | Chen, S, Ha, Y. | 登録日 | 2021-06-11 | 公開日 | 2021-06-30 | 最終更新日 | 2023-10-18 | 実験手法 | X-RAY DIFFRACTION (2.7 Å) | 主引用文献 | Pharmacological inhibition of PI5P4K alpha / beta disrupts cell energy metabolism and selectively kills p53-null tumor cells. Proc.Natl.Acad.Sci.USA, 118, 2021
|
|
7N7L
 
 | Crystal Structure of PI5P4KIIAlpha complex with BI-D1870 | 分子名称: | (7R)-2-[(3,5-difluoro-4-hydroxyphenyl)amino]-5,7-dimethyl-8-(3-methylbutyl)-7,8-dihydropteridin-6(5H)-one, Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha, SULFATE ION | 著者 | Chen, S, Ha, Y. | 登録日 | 2021-06-10 | 公開日 | 2021-06-30 | 最終更新日 | 2023-10-18 | 実験手法 | X-RAY DIFFRACTION (2.7 Å) | 主引用文献 | Pharmacological inhibition of PI5P4K alpha / beta disrupts cell energy metabolism and selectively kills p53-null tumor cells. Proc.Natl.Acad.Sci.USA, 118, 2021
|
|
7N80
 
 | Crystal Structure of PI5P4KIIBeta | 分子名称: | Phosphatidylinositol 5-phosphate 4-kinase type-2 beta | 著者 | Chen, S, Ha, Y. | 登録日 | 2021-06-11 | 公開日 | 2021-06-30 | 最終更新日 | 2023-10-18 | 実験手法 | X-RAY DIFFRACTION (2.5 Å) | 主引用文献 | Pharmacological inhibition of PI5P4K alpha / beta disrupts cell energy metabolism and selectively kills p53-null tumor cells. Proc.Natl.Acad.Sci.USA, 118, 2021
|
|
7N71
 
 | Crystal Structure of PI5P4KIIAlpha | 分子名称: | Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha, SULFATE ION | 著者 | Chen, S, Ha, Y. | 登録日 | 2021-06-09 | 公開日 | 2021-07-07 | 最終更新日 | 2023-10-18 | 実験手法 | X-RAY DIFFRACTION (2.5 Å) | 主引用文献 | Pharmacological inhibition of PI5P4K alpha / beta disrupts cell energy metabolism and selectively kills p53-null tumor cells. Proc.Natl.Acad.Sci.USA, 118, 2021
|
|
7DEY
 
 | |
8XCE
 
 | cocrystal structure of p53 in complex of B23 | 分子名称: | 2-[(2~{Z})-2-(3-ethynylphenyl)imino-4-oxidanylidene-1,3-thiazolidin-5-ylidene]ethanoic acid, Cellular tumor antigen p53, ZINC ION | 著者 | Wang, Z, Shujun, X, Yigang, T, Derun, Z, Jiaqi, W, Kai, K, Lu, M. | 登録日 | 2023-12-08 | 公開日 | 2025-06-11 | 実験手法 | X-RAY DIFFRACTION (2 Å) | 主引用文献 | cocrystal structure of p53 in complex of B23 To Be Published
|
|
7XK8
 
 | Cryo-EM structure of the Neuromedin U receptor 2 (NMUR2) in complex with G Protein and its endogeneous Peptide-Agonist NMU25 | 分子名称: | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-2, Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1, Guanine nucleotide-binding protein G(i) subunit alpha-1, ... | 著者 | Zhao, W, Wenru, Z, Mu, W, Minmin, L, Shutian, C, Tingting, T, Gisela, S, Holger, W, Albert, B, Cuiying, Y, Xiaojing, C, Han, S, Wu, B, Zhao, Q. | 登録日 | 2022-04-19 | 公開日 | 2023-02-22 | 最終更新日 | 2024-11-13 | 実験手法 | ELECTRON MICROSCOPY (3.3 Å) | 主引用文献 | Ligand recognition and activation of neuromedin U receptor 2. Nat Commun, 13, 2022
|
|
7UPY
 
 | An antibody from single human VH-rearranging mouse neutralizes all SARS-CoV-2 variants through BA.5 by inhibiting membrane fusion | 分子名称: | 2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose, ... | 著者 | Zhang, J, Luo, S, Kreutzberger, A, Kirchhausen, T, Chen, B, Haynes, B, Alt, F. | 登録日 | 2022-04-18 | 公開日 | 2022-08-10 | 最終更新日 | 2024-11-20 | 実験手法 | ELECTRON MICROSCOPY (3.1 Å) | 主引用文献 | An antibody from single human V H -rearranging mouse neutralizes all SARS-CoV-2 variants through BA.5 by inhibiting membrane fusion. Sci Immunol, 7, 2022
|
|